# USANA Updates 2026 Outlook With Sales Near $900 Million, Adjusted EBITDA About $77M

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/49345
Published: 2026-11-05T14:50:12.000Z
Updated: 2026-11-05T14:50:12.000Z
Section: Business

> The outlook reflects softer Rise Wellness expectations and Hiya marketing investment, partly offset by stronger profitability in Core Nutritional.

USANA Health Sciences, Inc. updated its fiscal 2026 outlook to consolidated net sales approaching $900 million and adjusted EBITDA of about $77 million.

The outlook reflects softer expectations for Rise Wellness and marketing investment in Hiya. USANA lowered its Rise outlook again, while its current Hiya sales outlook stands at $130 million. Stronger profitability in Core Nutritional partly offsets those pressures.

Hiya’s active monthly subscribers grew 18% sequentially. USANA’s active customer count declined 8% year over year, while Greater China accounted for most of the sequential declines in sales and customers. Management has identified customer growth as its top priority.